drugset
drugset / Trial / NCT04275115

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

NCT04275115 ↗

Phase 1 Completed 20 enrolled H. Lundbeck A/S
SequentialOpen-labelTreatment

Summary

The purpose of this study is to help determine which types of drugs that may interact with foliglurax

Timeline

Start
2020-02-10
Primary completion
2020-04-03
Completion
2020-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 200 mg Oral
Subject Foliglurax Small molecule — —
Subject Midazolam Small molecule 0.025 mg/kg Oral
Subject Midazolam Small molecule 4 mg Oral
Subject Montelukast Other / unclassified 10 mg Oral

Indications

No indication recorded.